IL-6 at the center of cytokine storm: Circulating inflammation mediators as biomarkers in hospitalized COVID-19 patients.
Hossein Mostafa ElbadawyAmin KhattabDina S El-AgamyHeba M EltahirAisha AlhaddadFahad Dakilallah AljohaniTarraji Mohammed AlmuzainiMekky M AbouziedAhmed AldhafiriPublished in: Journal of clinical laboratory analysis (2023)
Having the most significant correlations, IL-6 high levels in mechanically ventilated patients were shown to affect laboratory results, and, therefore, is suggested as a severity biomarker of COVID-19.